Award
Delivery Order #SPE2D326F256E
Pfizer Delivery Order for Injectable Tranexamic Acid
Buyer
Defense Logistics Agency
Award Amount
$449.20
Ceiling
$449.20
Awarded
July 13, 2026
Period of Performance
Jul 13, 2026 – Jul 14, 2026
Identifier
SPE2D326F256E
NAICS
325412
This delivery order under a Defense Logistics Agency indefinite-delivery contract procures CYKLOKAPRON (tranexamic acid), a 1,000 mg/10 mL injectable medicine, from Pfizer Inc., a pharmaceutical manufacturer. The product supports medical care by helping control or prevent bleeding, including in military healthcare settings. The order covers supply of the specified medication for performance in New York. It is issued under Pfizer’s broader DLA pharmaceutical contract, which is intended to provide essential medicines over a long-term period. The order record does not identify whether this individual purchase was competitively bid or sole-source, nor does it provide acquisition-program details, subcontractors, prior related orders, or the original solicitation. Performance is scheduled for a brief period in July 2026.
Description
4572364616!CYKLOKAPRON 1,000 MG/10 ML VL 10ML